Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$554M |
| 2 |
Broadcom
AVGO
|
+$378M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$324M |
| 4 |
Warner Bros
WBD
|
+$321M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$454M |
| 2 |
iShares MBS ETF
MBB
|
+$441M |
| 3 |
AT&T
T
|
+$266M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$198M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.98% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTYX
2726
DELISTED
Ventyx Biosciences
VTYX
| $1.19M | ﹤0.01% |
97,562
+23,759
| +32% | +$355K |
|
|
DBD
2727
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.19M | ﹤0.01% |
525,829
+692
| +0.1% | +$2.58K |
|
|
ACLX
2728
DELISTED
Arcellx
ACLX
| $1.19M | ﹤0.01% |
65,902
-761
| -1% | -$9.82K |
|
2729
Immunovant
IMVT
$7.93B
| $1.19M | ﹤0.01% |
305,132
+7,017
| +2% | +$30.3K |
|
2730
Alphatec Holdings
ATEC
$1.46B
| $1.19M | ﹤0.01% |
181,920
-2,717
| -1% | -$25K |
|
|
VBIV
2731
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $1.19M | ﹤0.01% |
49,049
-5,775
| -11% | -$197K |
|
2732
Vita Coco
COCO
$3.82B
| $1.19M | ﹤0.01% |
121,438
+33,460
| +38% | +$354K |
|
2733
Bioventus
BVS
$892M
| $1.19M | ﹤0.01% |
173,850
+3,681
| +2% | +$37.6K |
|
|
VLTA
2734
DELISTED
Volta Inc.
VLTA
| $1.18M | ﹤0.01% |
910,671
+302,608
| +50% | +$675K |
|
|
DOMA
2735
DELISTED
Doma Holdings, Inc.
DOMA
| $1.18M | ﹤0.01% |
45,770
+10,878
| +31% | +$462K |
|
|
IGMS
2736
DELISTED
IGM Biosciences
IGMS
| $1.18M | ﹤0.01% |
65,285
-37,338
| -36% | -$666K |
|
2737
Blend Labs
BLND
$431M
| $1.17M | ﹤0.01% |
497,451
+392,994
| +376% | +$1.47M |
|
2738
Equity Bancshares
EQBK
$1.04B
| $1.17M | ﹤0.01% |
40,108
+3,550
| +10% | +$111K |
|
|
ME
2739
DELISTED
23andMe Holding Co
ME
| $1.16M | ﹤0.01% |
23,420
+18,885
| +416% | +$1.09M |
|
2740
Atlassian
TEAM
$25.6B
| $1.15M | ﹤0.01% |
6,152
+165
| +3% | +$35.2K |
|
2741
Business First Bancshares
BFST
$1.04B
| $1.15M | ﹤0.01% |
53,868
+3,620
| +7% | +$80.3K |
|
2742
LSB Industries
LXU
$783M
| $1.14M | ﹤0.01% |
81,909
+69,679
| +570% | +$1.39M |
|
2743
Sweetgreen
SG
$766M
| $1.13M | ﹤0.01% |
96,854
+3,241
| +3% | +$68.4K |
|
2744
Caribou Biosciences
CRBU
$145M
| $1.13M | ﹤0.01% |
207,219
-7,326
| -3% | -$56K |
|
2745
Monte Rosa Therapeutics
GLUE
$1.4B
| $1.12M | ﹤0.01% |
116,234
-9,166
| -7% | -$92.1K |
|
2746
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.76B
| $1.12M | ﹤0.01% |
42,344
+30,307
| +252% | +$808K |
|
2747
Vuzix
VUZI
$194M
| $1.11M | ﹤0.01% |
157,002
-4,960
| -3% | -$29.1K |
|
2748
Luxfer Holdings
LXFR
$456M
| $1.11M | ﹤0.01% |
73,616
-400
| -0.5% | -$6.47K |
|
2749
Hingham Institution for Saving
HIFS
$627M
| $1.11M | ﹤0.01% |
3,911
-17
| -0.4% | -$5.34K |
|
2750
Offerpad Solutions
OPAD
$18.3M
| $1.11M | ﹤0.01% |
3,390
+997
| +42% | +$669K |
|
Similar funds
Charles Schwab's Q2 2022 Portfolio in Review
As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
- Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
- Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
- Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
- Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
- Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
- Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.
Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.